Atara Biotherapeutics, Inc. (ATRA)
NASDAQ·Healthcare·Biotechnology
$4.80
-3.91%
Mkt Cap $40.81M
Analyst Ratings
Buy
1
Hold
1
Sell
1
Price Target (6 analysts)
$15.50
Range $6.00 – $25.00
Implied Upside
+223.3%
Consensus $15.50 vs current $4.80
NASDAQ·Healthcare·Biotechnology
$4.80
-3.91%
Mkt Cap $40.81M
Buy
1
Hold
1
Sell
1
Price Target (6 analysts)
$15.50
Range $6.00 – $25.00
+223.3%
Consensus $15.50 vs current $4.80